Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

被引：1

作者：

Zhou, H. ^{[1
]}

Long, B. ^{[2
]}

Yu, Z. ^{[3
]}

Zhu, J. ^{[2
]}

Yang, H. ^{[4
]}

Zhang, W. ^{[3
]}

Guan, X. ^{[5
]}

Zhang, G. ^{[2
]}

Li, L. ^{[2
]}

Luo, C. ^{[2
]}

Cao, H. ^{[2
]}

Zhang, S. ^{[2
]}

Chen, S. ^{[2
]}

He, Q. ^{[2
]}

Gan, S. ^{[2
]}

Zhou, L. ^{[2
]}

Jiang, X. ^{[2
]}

Shi, W.

Huang, Z. ^{[5
]}

Mao, J. ^{[2
]}

Dong, C. ^{[6
]}

Jiao, Z. ^{[2
]}

机构：

[1] Gansu Prov Canc Hosp, Dept Abdominal Surg, Lanzhou, Peoples R China

[2] Lanzhou Univ Second Hosp, Dept Gen Surg, Lanzhou, Peoples R China

[3] Lanzhou Univ Second Hosp, Dept Radiol, Lanzhou, Peoples R China

[4] Lanzhou Univ Second Hosp, Cuiying Cent Lab, Lanzhou, Peoples R China

[5] Lanzhou Univ Second Hosp, Dept Gastroenterol, Lanzhou, Peoples R China

[6] Lanzhou Univ Second Hosp, Dept Pathol, Lanzhou, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-146

引用

页码：S66 / S67

页数：2

共 50 条

[41] Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study [J].

Chao Jing ;

Junyun Wang ;

Mingyue Zhu ;

Zhigang Bai ;

Baoyi Zhao ;

Jun Zhang ;

Jie Yin ;

Xiaobao Yang ;

Zongzhi Liu ;

Zhongtao Zhang ;

Wei Deng .

Cancer Immunology, Immunotherapy, 2022, 71 :2597-2608

[42] Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study [J].

Jing, Chao ;

Wang, Junyun ;

Zhu, Mingyue ;

Bai, Zhigang ;

Zhao, Baoyi ;

Zhang, Jun ;

Yin, Jie ;

Yang, Xiaobao ;

Liu, Zongzhi ;

Zhang, Zhongtao ;

Deng, Wei .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (11) :2597-2608

[43] Efficacy and safety of neoadjuvant chemoradiotherapy plus apatinib for patients with locally advanced, HER2-negative, Siewert's type II-III adenocarcinoma of esophagogastric junction: a single-arm, open-label, phase II trial [J].

Guo, Honghai ;

Li, Yong ;

Lin, Chi ;

Cheng, Yunjie ;

Zhang, Zhidong ;

Wang, Dong ;

Zhao, Xuefeng ;

Liu, Yu ;

Jing, Shaowu ;

Yang, Peigang ;

Tian, Yuan ;

Liu, Yang ;

Wang, Jun ;

Zhao, Qun .

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (08) :9015-9023

[44] A single-arm study of apatinib plus neoadjuvant chemotherapy followed by resection in patients with locally advanced colorectal adenocarcinoma [J].

Zhang, T. ;

Li, G. ;

Zhang, A. .

ANNALS OF ONCOLOGY, 2021, 32 :S131-S131

[45] Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy: Data update. [J].

Liu, Zimin ;

Liu, Ning ;

Zhou, Yanbing ;

Niu, Zhaojian ;

Jiang, Haitao ;

Zhu, Yingqian ;

Wang, Huiyun ;

Li, Xiaoxiao ;

Song, Shanai ;

Liu, Xiaodong ;

Li, Zequn ;

Zhao, Shufen .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) :E16044-E16044

[46] Tislelizumab combined with XELOX as a neoadjuvant therapy for locally advanced gastric and gastroesophageal junction adenocarcinomas: A prospective, phase II trial [J].

Zhou, Haikun ;

Han, Tao ;

Tuo, Lei ;

Yang, Qingchuan ;

Gao, Ruiqi ;

Yu, Pengfei ;

Wei, Jiangpeng ;

Zhu, Changbin ;

Wang, Jin ;

Cheng, Peng ;

Kang, Xiang ;

Pi, Sihui ;

Liu, Hui ;

Pan, Xiaoxi ;

Li, Xiaohua ;

Ji, Gang .

CANCER RESEARCH, 2024, 84 (06)

[47] Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma. [J].

Li, Hongli ;

Deng, Jingyu ;

Ge, Shaohua ;

Zang, Fenglin ;

Zhang, Le ;

Ren, Peng ;

Wang, Baogui ;

Cao, Fuliang ;

Deng, Ting ;

Liu, Rui ;

Ning, Tao ;

Yang, Yuchong ;

Bai, Ming ;

Wang, Xia ;

Ji, Zhi ;

Duan, Jingjing ;

Liu, Yong ;

Zhou, Dejun ;

Liang, Han ;

Ba, Yi .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[48] Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial [J].

Zhang, Peng-Fei ;

Zhang, Wei-Han ;

Liu, Xi-Jiao ;

He, Du ;

Yang, Kun ;

Gou, Hong-Feng ;

Hu, Jian-Kun .

BMJ OPEN, 2024, 14 (12)

[49] Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study [J].

Wu, Kunpeng ;

Li, Yahua ;

Li, Zongming ;

Zhou, Zihe ;

Ge, Xiaoyong ;

Li, Yifan ;

Han, Xinwei ;

Chen, Peng ;

Ren, Kewei .

FRONTIERS IN ONCOLOGY, 2023, 13

[50] The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial [J].

Huang, Nai-si ;

Wei, Wen-jun ;

Xiang, Jun ;

Chen, Jia-ying ;

Guan, Qing ;

Lu, Zhong-wu ;

Ma, Ben ;

Sun, Guo-hua ;

Wang, Yu-long ;

Ji, Qing-hai ;

Wang, Yu .

THYROID, 2021, 31 (12) :1808-1813

← 1 2 3 4 5 →